These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11265765)

  • 1. Graft-versus-host alloresponses to treat nonlymphohematopoietic tumors: is there a solid approach?
    Sykes M
    J Immunother; 2001; 24(2):101-3. PubMed ID: 11265765
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
    Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
    Pachnio A; Dietrich S; Klapper W; Humpe A; Schwake M; Sedlacek R; Gramatzki M; Beck C
    Bone Marrow Transplant; 2006 Jul; 38(2):157-67. PubMed ID: 16820783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematopoietic cell transplantation as immunotherapy.
    Appelbaum FR
    Nature; 2001 May; 411(6835):385-9. PubMed ID: 11357147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
    J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting beneficial alloreactive T cells.
    Barber LD; Madrigal JA
    Vox Sang; 2006 Jul; 91(1):20-7. PubMed ID: 16756597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allogeneic hematopoietic stem cell transplantation for solid tumors].
    Kanda Y
    Rinsho Ketsueki; 2004 Mar; 45(3):189-94. PubMed ID: 15103931
    [No Abstract]   [Full Text] [Related]  

  • 8. Posttransplant administration of cyclophosphamide and donor lymphocyte infusion induces potent antitumor immunity to solid tumor.
    Eto M; Kamiryo Y; Takeuchi A; Harano M; Tatsugami K; Harada M; Kiyoshima K; Hamaguchi M; Teshima T; Tsuneyoshi M; Yoshikai Y; Naito S
    Clin Cancer Res; 2008 May; 14(9):2833-40. PubMed ID: 18451251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells targeted against a single minor histocompatibility antigen can cure solid tumors.
    Meunier MC; Delisle JS; Bergeron J; Rineau V; Baron C; Perreault C
    Nat Med; 2005 Nov; 11(11):1222-9. PubMed ID: 16227989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host.
    Hummel S; Wilms D; Vitacolonna M; Zöller M
    J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice.
    Zeis M; Steinmann J; Petrela E; Hartung G; Schmitz N; Uharek L
    Bone Marrow Transplant; 2001 Feb; 27(3):279-85. PubMed ID: 11277175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cancer treatment with low levels of mixed chimerism induced by nonmyeloablative regimen using cyclophosphamide in mice.
    Harano M; Eto M; Iwai T; Tatsugami K; Kiyoshima K; Kamiryo Y; Tsuneyoshi M; Yoshikai Y; Naito S
    Cancer Res; 2005 Nov; 65(21):10032-40. PubMed ID: 16267029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early vaccination with tumor-lysate-pulsed dendritic cells after allogeneic bone marrow transplantation has antitumor effects.
    Moyer JS; Maine G; Mulé JJ
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1010-9. PubMed ID: 17084367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
    Suzuki Y; Adachi Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Ikehara S
    Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
    Hirshfeld E; Weiss L; Kasir J; Zeira M; Slavin S; Shapira MY
    Bone Marrow Transplant; 2006 Sep; 38(5):359-64. PubMed ID: 16862165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allogeneic hematopoetic cell transplantation in patients with solid tumors - Contra].
    Bokemeyer C; Kanz L
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2215. PubMed ID: 12397552
    [No Abstract]   [Full Text] [Related]  

  • 17. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
    Zöller M; Matzku S
    Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From tumor-host to feto-maternal relationship. Immunological studies.
    Pasqualini CD; Piazzon I; Matusevich M; Déroche A
    Prog Clin Biol Res; 1982; 87():277-87. PubMed ID: 6981118
    [No Abstract]   [Full Text] [Related]  

  • 20. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
    Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K
    J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.